Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0000899140-19-000274
Form Type:
13D Filing
Publication Date:
2019-03-04 11:05:20
Filed By:
Monarch Alternative Capital
Company:
Cimarex Resolute Llc (NYSE:REN)
Filing Date:
2019-03-04
SEC Url:
13D Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Monarch Alternative Capital 0 0 0 0 0 0%
MDRA GP 0 0 0 0 0 0%
Monarch GP 0 0 0 0 0 0%
Filing


SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


 
SCHEDULE 13D
Under the Securities Exchange Act of 1934*
(Amendment No. 5)


 
Resolute Energy Corporation
(Name of Issuer)
Common Stock, par value $0.0001
(Title of Class of Securities)
76116A306
(CUSIP Number of Class of Securities)
Michael Kelly, Esq.
Monarch Alternative Capital LP
535 Madison Avenue
New York, NY 10022
Telephone: (212) 554-1700
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
Copies to:
Mark Cognetti, Esq.
Michael Brandt, Esq.
Willkie Farr & Gallagher LLP
787 Seventh Avenue
New York, NY 10019-6099
(212) 728-8000
March 1, 2019
(Date of Event which Requires Filing of this Schedule)



If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box: ☐



NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 240.13d-7 for other parties to whom copies are to be sent.




*
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13D
CUSIP No.  76116A306
 
Page 2 of 5 Pages

 
1
 
NAME OF REPORTING PERSON
 
Monarch Alternative Capital LP
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
                                                                                                                                                         (a) ☐
                                                                                                                                                         (b) ☒
 
3
 
 
SEC USE ONLY
 
4
 
SOURCE OF FUNDS
N/A
5
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d)
or 2(e)
                                                                                                                                                         ☐
6
 
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF
SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH
7
 
SOLE VOTING POWER
0
8
 
SHARED VOTING POWER
0
9
 
SOLE DISPOSITIVE POWER
0
10
 
SHARED DISPOSITIVE POWER
0
11
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON
0
12
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES               
 
13
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
14
 
TYPE OF REPORTING PERSON*
PN, IA

SCHEDULE 13D
CUSIP No.  76116A306
 
Page 3 of 5 Pages

 
1
 
NAME OF REPORTING PERSON
 
MDRA GP LP
2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
                                                                                                                                                         (a) ☐
                                                                                                                                                         (b) ☒
 
3
 
 
SEC USE ONLY
4
 
SOURCE OF FUNDS
N/A
5
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d)
or 2(e)
                                                                                                                                                         ☐
6
 
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF
SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH
7
 
SOLE VOTING POWER
0
8
 
SHARED VOTING POWER
0
9
 
SOLE DISPOSITIVE POWER
0
10
 
SHARED DISPOSITIVE POWER
0
11
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON
0
12
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES               

13
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
14
 
TYPE OF REPORTING PERSON*
PN, HC


SCHEDULE 13D
CUSIP No.  76116A306
 
Page 4 of 5 Pages

 
1
 
NAME OF REPORTING PERSON
 
Monarch GP LLC

2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
                                                                                                                                                         (a) ☐
                                                                                                                                                         (b) ☒
 
3
 
 
SEC USE ONLY
 
4
 
SOURCE OF FUNDS
N/A
5
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d)
or 2(e)
                                                                                                                                                         ☐
6
 
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF
SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH
7
 
SOLE VOTING POWER
0
8
 
SHARED VOTING POWER
0
9
 
SOLE DISPOSITIVE POWER
0
10
 
SHARED DISPOSITIVE POWER
0
11
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON
0
12
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES               
 
13
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
14
 
TYPE OF REPORTING PERSON*
OO, HC


Pursuant to Rule 13d-2 promulgated under the Act, this Amendment No. 5 to Schedule 13D (this “Amendment No. 5”) is being filed with respect to the common stock, par value $0.0001 per share (“Common Stock”), of Resolute Energy Corporation (the “Issuer”), to amend the Schedule 13D filed on January 26, 2018 (the “Original 13D” and, as amended by Amendment No. 1 to Schedule 13D filed on February 9, 2018 (“Amendment No. 1”), Amendment No. 2 to Schedule 13D filed on March 12, 2018 (“Amendment No. 2”), Amendment No. 3 to Schedule 13D filed on May 16, 2018, Amendment No. 4 to Schedule 13D filed on November 19, 2018, and this Amendment No. 5, the “Schedule 13D”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Schedule 13D.
Item 4.
Purpose of Transaction
Item 4 of this Schedule 13D is hereby amended and supplemented to include the following:
On March 1, 2019, pursuant to the Merger Agreement, at the effective time of the Merger, each share of Common Stock and restricted stock of the Issuer was converted, at each Reporting Person’s option and subject to proration procedures as set forth in the Merger Agreement, into the right to receive an amount in cash, without interest, equal to $14.00 and 0.2366 validly issued, fully paid and non-assessable shares of common stock of Purchaser, par value $0.01 per share (“Purchaser Common Stock”). The closing price of Purchaser Common Stock on March 1, 2019 was $73.08.
Item 5.
Interests in Securities of the Issuer
Item 5(a)-(e) of this Schedule 13D is hereby amended and restated to read as follows:
(a) and (b) The Reporting Persons do not beneficially own any shares of Common Stock.
(c) Except as described in Item 4 of this Amendment No. 5, the Reporting Persons have not effected any transactions with respect to the Issuer’s Common Stock or restricted stock during the past sixty days.
(d) Not applicable.
(e) The Reporting Persons ceased to be the beneficial owners of 5% or more of the Issuer’s Common Stock on March 1, 2019.
[Signatures on following page]



SIGNATURES
After reasonable inquiry and to the best of our knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.
Dated: March 4, 2019
 
MONARCH ALTERNATIVE CAPITAL LP
By: MDRA GP LP, its General Partner
By: Monarch GP LLC, its General Partner
By: /s/ Michael Weinstock
Name: Michael Weinstock
Title: Member
   
Dated: March 4, 2019
 
MDRA GP LP
By: Monarch GP LLC, its General Partner
By: /s/ Michael Weinstock                  
Name: Michael Weinstock
Title: Member
   
Dated: March 4, 2019
 
MONARCH GP LLC
By: /s/ Michael Weinstock                  
Name: Michael Weinstock
Title: Member